Former Johnson & Johnson exec becomes CEO of InspireMD

Written by Alan Condon | December 11, 2019 | Print  |

InspireMD appointed Marvin Slosman as its new CEO, effective Jan. 1, reports EIN Newsdesk.

Four things to know:

1. Mr. Slosman will replace outgoing CEO James Barry, PhD. He will also fill Dr. Barry's seat on the company's board of directors.

2. His goal is to expand the availability of the company's CGuardTM Embolic Prevention System, designed for the prevention of stroke caused by carotid artery disease.

3. The CGuard system prevents peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining perfusion to the external carotid artery and branch vessels.

4. Mr. Slosman served in commercial leadership positions at Johnson & Johnson, GE Healthcare and Baxter, and is a former CEO of Ovalum.

More articles on devices:
3 orthopedic surgeons to expand services at new Iowa facility
2 recent value-based partnerships for orthopedic procedures
DePuy Synthes recalls devices used in spine fixation system: 6 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers